Tevogen TVGN
NASDAQ TVGN
$6.72 +0.10 (+1.51%)
As of: Oct 1, 2026 · 3:26 PM EDT

Tevogen (TVGN) Non-Current Debt (2024 - 2026)

Updated

Tevogen (TVGN) recorded Non-Current Debt of $6.4 million in Q1 2026, up 113.3% from $3 million a year earlier and up 45.5% from the prior quarter.

Analysis

Tevogen (TVGN) Non-Current Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, Tevogen reported Non-Current Debt of $4.4 million, up 340.0% from FY2024.

  • Across earlier years, Non-Current Debt came in at $1 million in FY2024.
  • Per Business Quant, the preceding three quarters came in at $4.4 million (Q4 2025), $4.4 million (Q3 2025) and $4.4 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 37.34 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 62.48 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -108.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 23.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tevogen 27.60 Mn 24.63 Mn - 6.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6.40 Mn
Dec 31, 2025 4.40 Mn
Sep 30, 2025 4.40 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 1.00 Mn
API Access

Tevogen Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TVGN&period=max&api_key=YOUR_API_KEY